New development regarding Barış Alper.

New development regarding Barış Alper.

09.09.2025 17:11

Galatasaray, which will face Eyüpspor away, is continuing its preparations for the match. The yellow-red team, which entered the international break as the leader, is experiencing injury problems. The situation of Victor Osimhen has raised concerns for the coaching staff. It has been learned that Barış Alper Yılmaz will be evaluated in the forward position against Eyüpspor, as both Osimhen and Mauro Icardi are unlikely to start in the lineup.

The Super Lig giant Galatasaray continues its preparations for the away match against Eyüpspor in the 5th week of the Super Lig. The yellow-red team, which entered the national team break as the leader with four wins out of four, is facing injury problems.

OSIMHEN INJURED

The situation of Victor Osimhen has worried the technical team. The star striker, who was injured in the ankle during Nigeria's match against Rwanda, left the game in the first half. After returning to Istanbul by private jet, all eyes were on the report from the medical team for the 26-year-old footballer. The yellow-red club announced that Osimhen has been diagnosed with moderate sprain and bleeding in the ligaments of his ankle.

ICARDI NOT READY

It is expected that the Nigerian striker will miss the Eyüpspor match in the Super Lig and will be ready for the away match against Eintracht Frankfurt in the Champions League. It has been reported that Mauro Icardi is also struggling physically and condition-wise to play the full 90 minutes at this stage.

BARIŞ ALPER WILL PLAY IN THE STARTING XI

In the squad arrangement where Osimhen and Icardi will not start, it has been learned that Barış Alper Yılmaz will be evaluated in the forward position against Eyüpspor.

In order to provide you with a better service, we position cookies on our site. Your personal data is collected and processed within the scope of KVKK and GDPR. For detailed information, you can review our Data Policy / Disclosure Text. By using our site, you agree to our use of cookies.', '